Published: Guidance, quality standards and advice

Skip to filters Skip to results

Showing 826 to 850 of 881

Sort by

Guidance programme: Technology appraisal guidanceRemove Guidance programme: Technology appraisal guidance filter

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Etanercept and efalizumab for treating moderate to severe plaque psoriasis	TA103	26 July 2006	1 September 2009
Alitretinoin for the treatment of severe chronic hand eczema	TA177	26 August 2009	26 August 2009
Bevacizumab (first-line), sorafenib (first- and second-line), sunitinib (second-line) and temsirolimus (first-line) for the treatment of advanced and/or metastatic renal cell carcinoma	TA178	26 August 2009	26 August 2009
Tenofovir disoproxil for the treatment of chronic hepatitis B	TA173	22 July 2009	22 July 2009
Rituximab for the first-line treatment of chronic lymphocytic leukaemia	TA174	22 July 2009	22 July 2009
Rivaroxaban for preventing venous thromboembolism after hip or knee replacement surgery	TA170	22 April 2009	22 April 2009
Sunitinib for the first-line treatment of advanced and/or metastatic renal cell carcinoma	TA169	25 March 2009	25 March 2009
Amantadine, oseltamivir and zanamivir for the treatment of influenza	TA168	25 February 2009	25 February 2009
Machine perfusion systems and cold static storage of kidneys from deceased donors	TA165	28 January 2009	28 January 2009
Infliximab for acute exacerbations of ulcerative colitis	TA163	17 December 2008	17 December 2008
Spinal cord stimulation for chronic pain of neuropathic or ischaemic origin	TA159	22 October 2008	22 October 2008
Dabigatran etexilate for preventing venous thromboembolism after hip or knee replacement surgery	TA157	24 September 2008	24 September 2008
Oseltamivir, amantadine (review) and zanamivir for the prophylaxis of influenza	TA158	24 September 2008	24 September 2008
Routine antenatal anti-D prophylaxis for women who are rhesus D negative	TA156	27 August 2008	27 August 2008
Entecavir for the treatment of chronic hepatitis B	TA153	27 August 2008	27 August 2008
Telbivudine for the treatment of chronic hepatitis B	TA154	27 August 2008	27 August 2008
Continuous subcutaneous insulin infusion for the treatment of diabetes mellitus	TA151	23 July 2008	23 July 2008
Cetuximab for the treatment of locally advanced squamous cell cancer of the head and neck	TA145	25 June 2008	25 June 2008
Adalimumab for treating moderate to severe plaque psoriasis	TA146	25 June 2008	25 June 2008
Bevacizumab for the treatment of non-small-cell lung cancer (terminated appraisal)	TA148	25 June 2008	25 June 2008
Carmustine implants for the treatment of recurrent glioblastoma multiforme (terminated appraisal)	TA149	25 June 2008	25 June 2008
Structural neuroimaging in first-episode psychosis	TA136	27 February 2008	27 February 2008
Rituximab for the treatment of relapsed or refractory stage 3 or 4 follicular non-Hodgkin's lymphoma	TA137	27 February 2008	27 February 2008
Infliximab for treating moderate to severe plaque psoriasis	TA134	23 January 2008	23 January 2008
Pemetrexed for the treatment of malignant pleural mesothelioma	TA135	23 January 2008	23 January 2008

Results per page

10
25
50
All